Axsome Therapeutics to Present New Sunosi® Data at SLEEP 2023

Cognitive improvement with Sunosi sustained over eight hours in patients with excessive daytime sleepiness due to obstructive sleep apneaNEW YORK, June 01, 2023 -- Axsome Therapeutics, Inc. , a... | June 1, 2023

Related Keywords

Germany ,United Kingdom ,Japan ,United States ,China ,New York ,British ,American ,German ,Darren Opland ,Hans Van Dongen ,Johannes Gutenberg ,Mark Jacobson ,Russell Rosenberg ,Research Society ,World Trade Center ,Drug Administration ,Neurotrials Research ,Nasdaq ,Corporate Communications ,Professor At Washington State University ,Us Drug Enforcement Agency On ,Sk Biopharmaceuticals Co Ltd ,Axsome Therapeutics Inc ,Medicine Center ,American Academy Of Sleep Medicine ,Department Of Neurology ,American Academy ,Sleep Medicine ,Sleep Research Society ,Cognitive Health ,Apnea Participants During ,Randomized Placebo Controlled ,Washington State University ,Obstructive Sleep Apnea ,Excessive Daytime Sleepiness ,Board Number ,Follow Up Experience ,Yaroslav Winter ,Mainz Comprehensive Epilepsy ,Sleep Medicine Center ,Johannes Gutenberg University ,Excessive Sleepiness ,Effect Sizes ,Numbers Needed ,Healthcare Resource Utilization Burden ,Gregory Parks ,Randomized Placebo Controlled Study ,Digit Symbol Substitution Test ,Repeatable Battery ,Neuropsychological Status ,Digit Symbol Substitution ,British Columbia Cognitive Complaints Inventory ,Patient Global Impression ,Epworth Sleepiness Scale ,Real World Experience ,Enforcement Agency ,Full Prescribing Information ,Medication Guide ,Axsome Therapeutics ,Nc Stock Exchange ,News ,Information ,Press Release ,Cognitive ,Improvement ,Ith ,Vsunosi ,Sustained ,Dover ,Flight ,Tours ,N ,Patients ,Excessive ,Daytime ,Sleepiness ,Ue ,O ,Obstructive ,Sleep ,Pneanew ,Pune ,023 ,Xsome Axsm Us05464t1043 ,